Has Sanjay Batra, MD received payments from drug or device companies?

Yes. Drug and device makers reported $83,608 in general payments to Sanjay Batra, MD across 470 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sanjay Batra, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sanjay Batra, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sanjay Batra, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Detroit, MINPI 1114981917

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (43.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 81.1% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2022 at $34,426 and has fallen 82.0% since, to $6,210 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$83,608in general payments, 2019–2025

Across 470 payments — averaging $177.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$68K
Atricure, Inc.$6K
Edwards Lifesciences$5K
Abiomed$2K
Abbott$765
Boston Scientific$443
plus $2K from 13 others

$325,451in research payments, 2019–2025

Across 139 payments — averaging $2341.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$312K
Livanova USA, Inc.$14K

What the payments were for

Speaking & faculty fees$36,74444%
Travel & lodging$14,48017%
Food & beverage$32,35339%
Education$310%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	313	$67,800
Atricure, Inc.	42	$6,002
Edwards Lifesciences	59	$5,183
Abiomed	13	$1,533
Abbott	5	$765
Boston Scientific	6	$443
Artivion, Inc.	2	$334
Kestra Medical Technology Services, Inc.	5	$307
Chiesi USA, Inc.	7	$202
Getinge USA Sales, LLC	3	$183
Terumo Cardiovascular Systems Corporation	2	$144
Teleflex LLC	2	$141
Inari Medical, Inc.	1	$133
Bard Access Systems, Inc.	2	$118
La Jolla Pharmaceutical Company	1	$115
LSI Solutions Inc	2	$65
Johnson & Johnson(2 entities)	2	$60
Davol Inc.	2	$55
Zimmer Biomet	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COREVALVE EVOLUT R$35,062
CoreValve Evolut$20,522
ATRICLIP LAA EXCLUSION SYSTEM$3,686
Avalus$3,279
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$2,115
SYNERGY ABLATION SYSTEM$1,639
ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$1,600
Mosaic$1,542
Impella$1,355
ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$1,322
APOLLOTM$681
INSPIRIS RESILIA aortic valve$644
3F$578
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$416
ATRICURE ATRICLIP LAA EXCLUSION$395
MITRIS RESILIA Mitral Valve$301
ATRICURE CRYOSURGICAL SYSTEM$255
Edwards SAPIEN 3 Transcatheter Heart Valve$254
BioGlue$195
On-X$195

How this compares

$83,608 in reported general payments places this provider in the 90th percentile of 182 thoracic surgery (cardiothoracic vascular surgery) providers in Michigan.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Michigan →

Medicare billing

Part B allowed, 2024

$88,876

Medicare patients

Services billed

149

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cephalexin	16	$171
Mupirocin	18	$124

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Detroit

Raed AlnajjarDetroit$781K
Zane HammoudDetroit$208K
Kyle MileticDetroit$22K
Hassan NemehDetroit$22K
Omar HabibDetroit$20K
Fouad AzouryDetroit$20K
Steven BollingAnn Arbor$41.7M
Gorav AilawadiAnn Arbor$434K
Reza DabirDearborn$342K
Shinichi FukuharaAnn Arbor$236K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →